Source: Abstract Book. Conference titles: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology/SBBq. Unidades: ICB, IQ
Subjects: DOR CRÔNICA, ANALGÉSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Beatriz Caroline de et al. New analgesic lead developed based on analysis of mutations in patients with congenital insensitivity to pain. 2022, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular, 2022. Disponível em: https://www2.sbbq.org.br/reuniao/2022/images/livro_completo.pdf. Acesso em: 26 ago. 2024.APA
Moraes, B. C. de, Ribeiro Filho, H. V., Roldão, A. P., Oliveira, V. R. da S., Toniolo, E. F., Goes, C. P., et al. (2022). New analgesic lead developed based on analysis of mutations in patients with congenital insensitivity to pain. In Abstract Book. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular. Recuperado de https://www2.sbbq.org.br/reuniao/2022/images/livro_completo.pdfNLM
Moraes BC de, Ribeiro Filho HV, Roldão AP, Oliveira VR da S, Toniolo EF, Goes CP, Dale CS, Oliveira PSL de, Schechtman D. New analgesic lead developed based on analysis of mutations in patients with congenital insensitivity to pain [Internet]. Abstract Book. 2022 ;[citado 2024 ago. 26 ] Available from: https://www2.sbbq.org.br/reuniao/2022/images/livro_completo.pdfVancouver
Moraes BC de, Ribeiro Filho HV, Roldão AP, Oliveira VR da S, Toniolo EF, Goes CP, Dale CS, Oliveira PSL de, Schechtman D. New analgesic lead developed based on analysis of mutations in patients with congenital insensitivity to pain [Internet]. Abstract Book. 2022 ;[citado 2024 ago. 26 ] Available from: https://www2.sbbq.org.br/reuniao/2022/images/livro_completo.pdf